Head to head

Selank vs Semax: Anxiolytic vs Nootropic, Not Interchangeable

Selank and Semax are often marketed side by side as a matched pair from the same research tradition. They were studied for different primary purposes, and conflating them obscures what each compound's citations actually support.

Human studies vs Limited direct evidenceEditorial review: September 14, 2026
Jorge Abreu is not a doctor. This is an educational research summary, not a prescription or a personal dosing plan. Study results do not establish that a supplier product is safe or effective for people. Consult a licensed clinician about medical decisions.
01

What each was studied for

Selank is a synthetic heptapeptide analog of tuftsin, studied in Russia primarily as an anxiolytic; an older comparative clinical study reported anxiolytic effects similar to a benzodiazepine comparator. Semax is a synthetic analog of an ACTH(4-10) fragment, studied in Russia for neuroprotective and nootropic properties, with much of the reviewed evidence coming from rat brain neuron research.

02

Evidence base and geography

Both compounds draw heavily on a specific body of Russian-language pharmacology literature that has not been widely replicated in Western randomized trials. Selank's clinical comparator study is closer to a human trial than most of Semax's rat-level evidence, but neither has the kind of large, independent replication that would settle their effects definitively.

03

Why the labels get mixed up

Because both are marketed as "cognitive" or "nootropic" peptides online, Selank's anxiety-focused evidence gets folded into general focus claims it was not designed to test. Semax's neuroprotective animal data gets similarly stretched toward everyday cognitive enhancement.

Bottom line: Pick based on the actual research question: anxiety-related effects point toward Selank's literature, neuroprotective and nootropic claims point toward Semax's, and neither should be assumed to cover the other's use case.

Read the full guides

Human studies

Selank

Neurologic research

Selank is a synthetic peptide analogue of tuftsin, an endogenous immunomodulatory tetrapeptide, extended with additional amino acids; it is not the same molecule as tuftsin itself, and findings for one should not be assumed to apply directly to the other.

Read the research →
Limited direct evidence

Semax

Neurologic research

Semax is a synthetic peptide built on the ACTH(4-10) sequence with added amino acids (sometimes described as ACTH(4-7)PGP), distinct from natural ACTH itself and from related synthetic analogues such as ACTH(6-9)PGP studied in the same research programs.

Read the research →

Reign Peptide · Business disclosure

Research product listings

Jorge Abreu is involved in Reign Peptide. Links to Reign are a business connection, not an independent endorsement. Reign lists these products for laboratory research, not human consumption.

Use the listing to check the labeled identity, amount and available batch documentation. A purity result alone does not verify sterility, clinical suitability or equivalence to a medicine used in a trial.

Names and sizes are product labels, not dosing recommendations. Confirm current details with the seller.